| __timestamp | Protagonist Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 94231000 |
| Thursday, January 1, 2015 | 11831000 | 146394000 |
| Friday, January 1, 2016 | 25705000 | 188272000 |
| Sunday, January 1, 2017 | 46181000 | 166707000 |
| Monday, January 1, 2018 | 59497000 | 401843000 |
| Tuesday, January 1, 2019 | 65003000 | 560909000 |
| Wednesday, January 1, 2020 | 74506000 | 722343000 |
| Friday, January 1, 2021 | 126006000 | 771182000 |
| Saturday, January 1, 2022 | 126215000 | 877090000 |
| Sunday, January 1, 2023 | 120161000 | 877387000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Protagonist Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Sarepta's R&D expenses surged by over 830%, peaking in 2023 with a staggering 877 million dollars. This reflects their aggressive pursuit of cutting-edge therapies. In contrast, Protagonist Therapeutics, while showing a steady increase, reached a more modest 120 million dollars in 2023, marking a 1,500% increase since 2014. This disparity highlights Sarepta's dominant position in prioritizing innovation, investing nearly seven times more than Protagonist in recent years. As the biotech landscape evolves, these spending patterns may shape the future of medical breakthroughs.
R&D Spending Showdown: AstraZeneca PLC vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Protagonist Therapeutics, Inc.
Research and Development Investment: Gilead Sciences, Inc. vs Protagonist Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Protagonist Therapeutics, Inc.
GSK plc vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Viridian Therapeutics, Inc.